Wordt geladen...
Pilot trial of sunitinib therapy in patients with von Hippel–Lindau disease
Background: Von Hippel–Lindau (VHL) disease induces vascular neoplasms in multiple organs. We evaluated the safety and efficacy of sunitinib in VHL patients and examined the expression of candidate receptors in archived tissue. Methods: Patients with VHL were given four cycles of 50 mg sunitinib dai...
Bewaard in:
| Gepubliceerd in: | Ann Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4542805/ https://ncbi.nlm.nih.gov/pubmed/22105611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdr011 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|